TY - JOUR
T1 - Impact of using the updated EWGSOP2 definition in diagnosing sarcopenia
T2 - A clinical perspective
AU - Van Ancum, Jeanine M.
AU - Alcazar, Julian
AU - Meskers, Carel G.M.
AU - Nielsen, Barbara Rubæk
AU - Suetta, Charlotte
AU - Maier, Andrea B.
PY - 2020/9/1
Y1 - 2020/9/1
N2 - Background and Purpose: The revised European Working Group on Sarcopenia in Older People (EWGSOP2, version 2019) definition of sarcopenia differs with respect to the EWGSOP (version 2010) definition in applied criteria and their cut-off values. We aimed to investigate the impact of the new definition on sarcopenia prevalence in various populations of older adults. Methods: Eight cohorts, including community-dwelling older adults, geriatric outpatients and patients admitted to acute and subacute inpatient wards were assessed on sarcopenia prevalence. Results: A total of 2256 participants (56.4 % female) were included with a median age of the cohorts of 71.7–83.3 years. In males, sarcopenia prevalence was 31.9 % according to EWGSOP compared to 12.0 % according to EWGSOP2. In females, sarcopenia prevalence was 4.9 % and 6.1 % according to EWGSOP and EWGSOP2 respectively. Lower cut-off points for handgrip strength (27 kg versus 30 kg (males) and 16 kg versus 20 kg (females) for EWGSOP and EWGSOP2 respectively) resulted in the lower sarcopenia prevalence in males. Conclusions: According to the EWGSOP2 definition, the prevalence of sarcopenia in males is significantly lower compared to the EWGSOP definition, whereas the prevalence among women is slightly higher. The lower cut-off points for handgrip strength result in fewer adults being diagnosed with sarcopenia.
AB - Background and Purpose: The revised European Working Group on Sarcopenia in Older People (EWGSOP2, version 2019) definition of sarcopenia differs with respect to the EWGSOP (version 2010) definition in applied criteria and their cut-off values. We aimed to investigate the impact of the new definition on sarcopenia prevalence in various populations of older adults. Methods: Eight cohorts, including community-dwelling older adults, geriatric outpatients and patients admitted to acute and subacute inpatient wards were assessed on sarcopenia prevalence. Results: A total of 2256 participants (56.4 % female) were included with a median age of the cohorts of 71.7–83.3 years. In males, sarcopenia prevalence was 31.9 % according to EWGSOP compared to 12.0 % according to EWGSOP2. In females, sarcopenia prevalence was 4.9 % and 6.1 % according to EWGSOP and EWGSOP2 respectively. Lower cut-off points for handgrip strength (27 kg versus 30 kg (males) and 16 kg versus 20 kg (females) for EWGSOP and EWGSOP2 respectively) resulted in the lower sarcopenia prevalence in males. Conclusions: According to the EWGSOP2 definition, the prevalence of sarcopenia in males is significantly lower compared to the EWGSOP definition, whereas the prevalence among women is slightly higher. The lower cut-off points for handgrip strength result in fewer adults being diagnosed with sarcopenia.
KW - Change management
KW - Classification
KW - Muscle atrophy
KW - Muscle strength
KW - Physical functional performance
KW - Skeletal muscle
UR - http://www.scopus.com/inward/record.url?scp=85086117144&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85086117144&partnerID=8YFLogxK
U2 - https://doi.org/10.1016/j.archger.2020.104125
DO - https://doi.org/10.1016/j.archger.2020.104125
M3 - Article
C2 - 32534364
SN - 0167-4943
VL - 90
SP - 1
EP - 8
JO - Archives of gerontology and geriatrics
JF - Archives of gerontology and geriatrics
M1 - 104125
ER -
